Creative Planning’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Sell
108,033
-5,281
-5% -$122K ﹤0.01% 1843
2026
Q1
$2.33M Buy
113,314
+31,076
+38% +$700K ﹤0.01% 1780
2025
Q4
$1.95M Buy
82,238
+4,529
+6% +$110K ﹤0.01% 1744
2025
Q3
$1.93M Buy
77,709
+26,080
+51% +$561K ﹤0.01% 1571
2025
Q2
$1.19M Sell
51,629
-1,015
-2% -$23.5K ﹤0.01% 1715
2025
Q1
$1.18M Buy
52,644
+6,585
+14% +$153K ﹤0.01% 1587
2024
Q4
$900K Buy
46,059
+20,072
+77% +$398K ﹤0.01% 1722
2024
Q3
$473K Buy
25,987
+5,542
+27% +$106K ﹤0.01% 2159
2024
Q2
$355K Buy
20,445
+7,217
+55% +$128K ﹤0.01% 2222
2024
Q1
$259K Buy
+13,228
New +$279K ﹤0.01% 2370

Other funds holding PRVA

Creative Planning's PRVA Position: Q2 2026 in Review

Creative Planning reduced its Privia Health (PRVA) stake by 4.7% in Q2 2026, selling an estimated $122K and leaving 108,033 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

Creative Planning first reported a position in PRVA in Q1 2024 and has held it in 10 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Creative Planning held 108,033 shares of Privia Health worth $2.78M as of Q2 2026.
  • Creative Planning sold 5,281 Privia Health shares in Q2 2026, an estimated $122K.
  • Privia Health made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1843 holding.
  • Creative Planning first reported a position in Privia Health in Q1 2024 and has held it in 10 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.